Laid off from Ginkgo Bioworks.

Ginkgo Bioworks told the Boston Business Journal that no layoffs beyond those then under way were planned, a statement its later filings show didn't hold up. Zymergen, which Ginkgo bought in 2022, cut jobs for the merger and later filed for bankruptcy while Ginkgo still owned it.

What we know about Ginkgo Bioworks severance and layoffs

  • More than 50% workforce reduction in the restructuring Ginkgo began in June 2024
  • 158 Boston and Cambridge jobs in Ginkgo's June 2024 Massachusetts WARN notice
  • 47 Emeryville, California jobs in Ginkgo's June 2024 WARN notices
  • $31.0 million to $32.0 million in cash severance and related costs, Ginkgo estimated
  • $11.1 million in severance and stock costs for Zymergen's 2022 merger cuts
  • 101 Zymergen jobs in a notice dated the day it filed for bankruptcy

The most recent Ginkgo Bioworks layoff we've found

The reductions Ginkgo began in June 2024 had substantially concluded by December 31, 2025, according to its quarterly report through September 2026, and it booked no restructuring charges in 2026 through September 30, against $8.8 million over the same months of 2025.

What Ginkgo Bioworks layoffs have meant for employees

If your Ginkgo job ended in 2025, Ginkgo counts that exit, in its filings, among the cuts of the restructuring it began in June 2024. The figures the company gave along the way don't all measure the same thing. In its May 2024 8-K the at-least-25% figure applied to labor expenses, in its amended 8-K the at-least-35% applied to the workforce, and the 10-K Ginkgo filed for 2025 gives a larger workforce figure for the plan as finished. So if someone tells you Ginkgo cut 35% of its staff, that was the June expectation. Chief executive Jason Kelly posted on X that the layoffs were completed June 24, according to GEN, and a spokesman said in a Boston Globe story that STAT carried that more notices would go to the state the following week, but the plan kept growing after both.

The money grew with the plan. Ginkgo expected the first wave alone to cost at least $12 million in severance and related separation costs, the amended 8-K said, and the 10-K's estimate for the whole reduction in force came in well above that, primarily in the Cell Engineering segment. Ginkgo booked $19.3 million in combined employee termination and other restructuring costs for 2024 and kept booking such costs through 2025. The 10-K also says Ginkgo didn't keep those employees past a minimum retention period, one of the reasons Ginkgo gives for booking each person's termination cost on the day the person was told. In the quarterly report through September 2026, Ginkgo shows the last $2.6 million it had accrued for those costs paid out in cash.

The restructuring also shrank Ginkgo's footprint. The 10-K says the company combined office and laboratory operations into fewer locations, subleased unused or underused space and sold its subsidiary Altar in 2024's third quarter, and in its quarterly report Ginkgo said it expected the subleasing to go on at least through 2026. If your Ginkgo job was in Massachusetts or California, there's more on claiming jobless benefits in Massachusetts or California. If one of the Emeryville notices covered you, the effective dates in California's WARN listing for 2023-24, August 16 and August 23, 2024, are dates for each filing as a whole, and they aren't necessarily the day your job ended.

For Zymergen's staff, the changes began before Ginkgo owned the company. Zymergen made its 2022 cuts in stages under the merger agreement, for "the benefit of the combined company," in the words of Ginkgo's 2024 annual filing, and Ginkgo issued replacement RSUs and Class A shares of its own under those cuts. Once the purchase closed, Ginkgo ran Zymergen as a distinct legal entity, separate from Ginkgo, and the October 2023 bankruptcy filing was Zymergen's alone. Ginkgo's bid for Zymergen's assets included acquiring its workforce. Zymergen concluded its auction on December 14, 2023, the bankruptcy court approved the sale on December 21, 2023, and when it closed in January 2024, Ginkgo offered jobs to some of Zymergen's employees. On February 5, 2024, the bankruptcy court confirmed the plan to liquidate Zymergen, and Ginkgo's interests in the Zymergen entities ended on February 23.

In his X post on the June cuts, Kelly also vouched for the people leaving. Writing that Ginkgo "had to let go of many truly excellent Bioworkers," he called them "truly amazing folks with unique skills" and told other employers they "should be very happy to hire them," GEN reported. If that first wave included you, you can point a recruiter to that post while you look for work.

A sourced history of Ginkgo Bioworks layoffs

  • 2025, Ginkgo's reductions continue all year

    Ginkgo's reductions ran throughout 2025 and were substantially complete that year, its 2025 annual filing says. It recorded $11.4 million of employee termination costs and other items for 2025 and had 485 employees on December 31.

  • June 2024, Ginkgo's layoffs begin

    Cuts began June 17, 2024, and Ginkgo expected them to total at least 35% of the workforce, its amended 8-K said. A spokesperson said no more were planned at that point, the Business Journal reported.

  • May 2024, Ginkgo approves a restructuring to cut labor costs

    Management approved a restructuring plan on May 9, 2024, its May 2024 8-K said. Ginkgo then expected labor expenses to fall at least 25%, headcount reductions to start that quarter and annualized operating spending to drop $200 million by mid-2025.

  • October 2023, Zymergen files for Chapter 11

    Zymergen, wholly owned by Ginkgo, filed on October 3, 2023, the notice date EDD's 2023-24 WARN listing gives for 101 Emeryville layoffs. Ginkgo bought substantially all its assets on January 18, 2024, offering jobs to 91 of its employees, per the 2024 Form 10-K.

  • July and August 2022, Zymergen cuts under the merger deal

    Zymergen cut 80 jobs in July 2022 and 80 more in August, soon after Ginkgo announced the purchase, BioSpace reported. Under the merger agreement it cut in stages, according to Ginkgo's 2024 10-K, and the deal closed October 19, 2022.

What to do if you're laid off from Ginkgo Bioworks

Ginkgo Bioworks layoff and severance questions

How many employees did Ginkgo Bioworks lay off?

Ginkgo's filings give the overall cut as a share rather than a head count, and the Form 10-K covering 2025 says the restructuring's workforce reduction was more than 50%, with cuts from June 2024 through 2025. When the layoffs began it expected at least 35%, which GEN worked out to at least 426 jobs from the 1,218 employees Ginkgo had at the end of 2023.

What severance has Ginkgo Bioworks given laid-off employees?

For the cuts that began in June 2024, Ginkgo set up a one-time employee termination benefit and gave the reduction in force's cash severance and related costs as a single company-wide estimate, its annual filing for 2025 says. Neither that filing nor GEN's June 2024 report gives a per-person figure.

Did Ginkgo Bioworks file WARN notices for its layoffs?

Yes, in June 2024, for 158 positions in Massachusetts and 47 in Emeryville, California, GEN reported, and EDD's 2023-24 WARN listing gives the Emeryville addresses as 5858 Horton St. and 1440 Stanford Ave. Our WARN tracker has nothing from Ginkgo after June 24, 2024.

Why did Ginkgo Bioworks lay off employees?

Chief executive Jason Kelly said the people let go in June 2024 were part of "changes we are making to our technology platform at Ginkgo and a near term focus on reaching breakeven," in a statement quoted by STAT. In its May 2024 8-K, Ginkgo tied the restructuring to its plans to reduce operating spending, and set a goal at the time of a $200 million annualized reduction by mid-2025.

What severance did Zymergen employees get in the Ginkgo merger?

Zymergen staff cut in stages under the 2022 merger agreement received enhanced severance, cash bonuses and accelerated vesting of their Zymergen stock units, set off by a change in control within twelve months of each termination date, Ginkgo's 2024 10-K says. For its August 2022 cut, Zymergen expected to pay about $3.8 million in cash severance, BioSpace reported.

Sources for this page